Top

Published in:

01-10-2016 | Original Article

Experimental verification of a predicted novel microRNA located in human PIK3CA gene with a potential oncogenic function in colorectal cancer

Authors: Ali Jason Saleh, Bahram M. Soltani, Sadat Dokanehiifard, Abdallah Medlej, Mahmoud Tavalaei, Seyed Javad Mowla

Published in: Tumor Biology | Issue 10/2016

Abstract

PI3K/AKT signaling is involved in cell survival, proliferation, and migration. In this pathway, PI3Kα enzyme is composed of a regulatory protein encoded by p85 gene and a catalytic protein encoded by PIK3CA gene. Human PIK3CA locus is amplified in several cancers including lung and colorectal cancer (CRC). Therefore, microRNAs (miRNAs) that are encoded within the PIK3CA gene might have a role in cancer development. Here, we report a novel microRNA named PIK3CA-miR1 (EBI accession no. LN626315), which is located within PIK3CA gene. A DNA segment corresponding to PIK3CA-premir1 sequence was transfected in human cell lines that resulted in generation of mature exogenous PIK3CA-miR1. Following the overexpression of PIK3CA-miR1, its predicted target genes (APPL1 and TrkC) were significantly downregulated in the CRC-originated HCT116 and SW480 cell lines, detected by qRT-PCR. Then, dual luciferase assay supported the interaction of PIK3CA-miR1 with APPL1 and TrkC transcripts. Endogenous PIK3CA-miR1 expression was also detected in several cell lines (highly in HCT116 and SW480) and highly in CRC specimens. Consistently, overexpression of PIK3CA-premir1 in HCT116 and SW480 cells resulted in significant reduction of the sub-G1 cell distribution and apoptotic cell rate, as detected by flowcytometry, and resulted in increased cell proliferation, as detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. PIK3CA-miR1 overexpression also resulted in Wnt signaling upregulation detected by Top/Fop assay. Overall, accumulative evidences indicated the presence of a bona fide novel onco-miRNA encoded within the PIK3CA oncogene, which is highly expressed in colorectal cancer and has a survival effect in CRC-originated cells.

Hiles ID et al. Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit. Cell. 1992;70:419–29.CrossRefPubMed

Volinia S et al. Molecular cloning, cDNA sequence, and chromosomal localization of the human phosphatidylinositol 3-kinase p110α (PIK3CA) gene. Genomics. 1994;24:472–7.CrossRefPubMed

Carpenter C et al. Purification and characterization of phosphoinositide 3-kinase from rat liver. J Biol Chem. 1990;265:19704–11.PubMed

Gkeka P et al. Investigating the structure and dynamics of the PIK3CA wild-type and H1047R oncogenic mutant. PLoS Comput Biol. 2014;10:e1003895.CrossRefPubMedPubMedCentral

Bader AG et al. Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer. 2005;5:921–9.CrossRefPubMed

Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet. 2006;7:606–19.CrossRefPubMed

Katso R et al. Cellular function of phosphoinositide 3-kinases: implications for development, immunity, homeostasis, and cancer. Annu Rev Cell Dev Biol. 2001;17:615–75.CrossRefPubMed

Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase—AKT pathway in human cancer. Nat Rev Cancer. 2002;2:489–501.CrossRefPubMed

Karakas B, Bachman K, Park B. Mutation of the PIK3CA oncogene in human cancers. Br J Cancer. 2006;94:455–9.CrossRefPubMedPubMedCentral

10.

Samuels Y, Waldman T. Oncogenic mutations of PIK3CA in human cancers. Curr Top Microbiol Immunol. 2010;347:21–41.PubMedPubMedCentral

11.

Gomes AQ, Nolasco S, Soares H. Non-coding RNAs: multi-tasking molecules in the cell. Int J Mol Sci. 2013;14:16010–39.CrossRefPubMedPubMedCentral

12.

Wang B. Base composition characteristics of mammalian miRNAs. J Nucleic Acids. 2013;2013:6.CrossRef

13.

Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–97.CrossRefPubMed

14.

Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010;11:597.PubMed

15.

Wang Z. MicroRNA: a matter of life or death. World J Biol Chem. 2010;1:41.CrossRefPubMedPubMedCentral

16.

Lin SL, Miller JD, Ying SY. Intronic microRNA (miRNA). J Biomed Biotechnol. 2006;2006:26818.CrossRefPubMedPubMedCentral

17.

Rodriguez A et al. Identification of mammalian microRNA host genes and transcription units. Genome Res. 2004;14:1902–10.CrossRefPubMedPubMedCentral

18.

Miranda KC et al. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell. 2006;126:1203–17.CrossRefPubMed

19.

Berezikov E, Cuppen E, Plasterk RH. Approaches to microRNA discovery. Nat Genet. 2006;38:S2–7.CrossRefPubMed

20.

Berezikov E et al. Phylogenetic shadowing and computational identification of human microRNA genes. Cell. 2005;120:21–4.CrossRefPubMed

21.

Heist RS, Sequist LV, Engelman JA. Genetic changes in squamous cell lung cancer: a review. J Thorac Oncol. 2012;7:924.CrossRefPubMedPubMedCentral

22.

Hussenet T, et al. SOX2 is an oncogene activated by recurrent 3q26. 3 amplifications in human lung squamous cell carcinomas. Plos One. 2010; 29: 5:e8960.

23.

Jehan Z et al. Frequent PIK3CA gene amplification and its clinical significance in colorectal cancer. J Pathol. 2009;219:337–46.CrossRefPubMed

24.

Maragkakis M et al. Accurate microRNA target prediction correlates with protein repression levels. BMC Bioinformatics. 2009;10:295.CrossRefPubMedPubMedCentral

25.

Maragkakis M et al. DIANA-microT Web server: elucidating microRNA functions through target prediction. Nucleic Acids Res. 2009;37:W273–6.CrossRefPubMedPubMedCentral

26.

Kanellos I, et al. MR-microT: a MapReduce-based MicroRNA target prediction method. In: Proceedings of the 26th International Conference on Scientific and Statistical Database Management. 2014; ACM.

27.

Reczko M et al. Functional microRNA targets in protein coding sequences. Bioinformatics. 2012;28:771–6.CrossRefPubMed

28.

Maniatis T, EF Fritsch and J Sambrook. Molecular cloning: a laboratory manual. Vol. 545. 1982: Cold Spring Harbor Laboratory Cold Spring Harbor, NY.

29.

Xu N et al. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell. 2009;137:647–58.CrossRefPubMed

30.

Parsi S et al. Experimental verification of a predicted intronic microRNA in human NGFR gene with a potential pro-apoptotic function. PLoS One. 2012;7:e35561.CrossRefPubMedPubMedCentral

31.

Mestdagh P et al. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol. 2009;10:R64.CrossRefPubMedPubMedCentral

32.

Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods. 2001;25:402–8.CrossRefPubMed

33.

Schickel R et al. MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene. 2008;27:5959–74.CrossRefPubMed

34.

Neilsen CT, Goodall GJ, Bracken CP. IsomiRs—the overlooked repertoire in the dynamic microRNAome. Trends Genet. 2012;28:544–9.CrossRefPubMed

35.

Li L et al. Computational approaches for microRNA studies: a review. Mamm Genome. 2010;21:1–12.CrossRefPubMed

36.

Winter J et al. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol. 2009;11:228–34.CrossRefPubMed

37.

Ahmed D et al. Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis. 2013;2:e71.CrossRefPubMedPubMedCentral

38.

Monteys AM et al. Structure and activity of putative intronic miRNA promoters. RNA. 2010;16:495–505.CrossRefPubMedPubMedCentral

39.

Ozsolak F et al. Chromatin structure analyses identify miRNA promoters. Genes Dev. 2008;22:3172–83.CrossRefPubMedPubMedCentral

40.

Brennecke J et al. Principles of microRNA-target recognition. PLoS Biol. 2005;3:e85.CrossRefPubMedPubMedCentral

41.

Genevois AL et al. Dependence receptor TrkC is a putative colon cancer tumor suppressor. Proc Natl Acad Sci U S A. 2013;110:3017–22.CrossRefPubMedPubMedCentral

42.

Jin W et al. TrkC plays an essential role in breast tumor growth and metastasis. Carcinogenesis. 2010;31:1939–47.CrossRefPubMed

43.

Luo Y et al. NTRK3 is a potential tumor suppressor gene commonly inactivated by epigenetic mechanisms in colorectal cancer. PLoS Genet. 2013;9:e1003552.CrossRefPubMedPubMedCentral

44.

Reichardt LF. Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond Ser B Biol Sci. 2006;361:1545–64.CrossRef

45.

Lee JR et al. Adaptor protein containing PH domain, PTB domain and leucine zipper (APPL1) regulates the protein level of EGFR by modulating its trafficking. Biochem Biophys Res Commun. 2011;415:206–11.CrossRefPubMed

46.

Mitsuuchi Y et al. Identification of a chromosome 3p14. 3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine/threonine kinase AKT2. Oncogene. 1999;18:4891–8.CrossRefPubMed

47.

Nechamen CA, Thomas RM, Dias JA. APPL1, APPL2, Akt2 and FOXO1a interact with FSHR in a potential signaling complex. Mol Cell Endocrinol. 2007;260:93–9.CrossRefPubMed

48.

Yang L et al. APPL suppresses androgen receptor transactivation via potentiating Akt activity. J Biol Chem. 2003;278:16820–7.CrossRefPubMed

49.

Liu J et al. Mediation of the DCC apoptotic signal by DIP13α. J Biol Chem. 2002;277:26281–5.CrossRefPubMed

50.

Kiriakidou M et al. A combined computational-experimental approach predicts human microRNA targets. Genes Dev. 2004;18:1165–78.CrossRefPubMedPubMedCentral

51.

Schneider M et al. Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker. BMC Cancer. 2012;12:96.CrossRefPubMedPubMedCentral

52.

Flatmark K et al. Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude mice. Eur J Cancer. 2004;40:1593–8.CrossRefPubMed

53.

Dokanehiifard S et al. Experimental verification of a conserved intronic microRNA located in the human TrkC gene with a cell type-dependent apoptotic function. Cell Mol Life Sci. 2015;72:1–13.CrossRef

54.

Deepa SS, Dong LQ. APPL1: role in adiponectin signaling and beyond. Am J Physiol Endocrinol Metab. 2009;296:E22–36.CrossRefPubMed

55.

Rashid S et al. Endosomal adaptor proteins APPL1 and APPL2 are novel activators of β-catenin/TCF-mediated transcription. J Biol Chem. 2009;284:18115–28.CrossRefPubMedPubMedCentral

Title: Experimental verification of a predicted novel microRNA located in human PIK3CA gene with a potential oncogenic function in colorectal cancer
Authors: Ali Jason Saleh
Bahram M. Soltani
Sadat Dokanehiifard
Abdallah Medlej
Mahmoud Tavalaei
Seyed Javad Mowla
Publication date: 01-10-2016
Publisher: Springer Netherlands
Published in: Tumor Biology / Issue 10/2016
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-016-5264-y

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2016

miRNA-451 inhibits glioma cell proliferation and invasion by downregulating glucose transporter 1

Extracellular HSP70-peptide complexes promote the proliferation of hepatocellular carcinoma cells via TLR2/4/JNK1/2MAPK pathway

MicroRNA-15a inhibits the growth and invasiveness of malignant melanoma and directly targets on CDCA4 gene

P2RX7-V3 is a novel oncogene that promotes tumorigenesis in uveal melanoma

Tescalcin expression contributes to invasive and metastatic activity in colorectal cancer

Tumor biology of non-metastatic stages of clear cell renal cell carcinoma; overexpression of stearoyl desaturase-1, EPO/EPO-R system and hypoxia-related proteins

Keynote webinar | Spotlight on antibody–drug conjugates in cancer